Globus Medical, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Keith W. Pfeil
- Full Time Employees
- 6,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 2560 General Armistead Avenue Audubon PA United States of America 19403-5214
- IPO Date
- Aug 3, 2012
- CIK
- 0001237831
- Website
- globusmedical.com
- Similar Companies
- Business
- Globus Medical, Inc. is a leading musculoskeletal solutions company specializing in the design, development, manufacturing, and commercialization of a broad portfolio of products for the spine, orthopedic trauma, and neuromodulation markets. Its core product offerings include spinal implants and biologics; orthopedic trauma fixation devices such as plates, nails, and screws; joint reconstruction products including hip and knee systems; enabling technologies like surgical navigation and robotics; and high-frequency neuromodulation devices for chronic pain management. The company operates extensively across the United States and has an expanding international presence, serving hospitals, ambulatory surgery centers, and healthcare providers. Founded in 2003, Globus Medical is headquartered in Audubon, Pennsylvania. Recent major developments include the strategic acquisition of Nevro Corporation in early 2025, which significantly broadened Globus Medical's neuromodulation portfolio with advanced high-frequency spinal cord stimulation technology, positioning the company to access a $2.5 billion market opportunity. The company also continues to expand its orthopedic trauma product line with several new FDA-cleared systems in 2024 and 2025, including the TENSOR Suture Button System, ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments, and CAPTIVATE SOLA Headless Screws. Additionally, Globus Medical launched innovative anterior lumbar interbody fusion products such as the COHERE ALIF Spacer and Modulus ALIF Blades in 2025, enhancing its spine surgery portfolio. The company is undergoing integration of recent acquisitions including NuVasive to realize operational synergies while focusing on organic innovation, enhanced surgeon engagement, and scaling its hip and knee business. Globus Medical's industry segments encompass spinal surgery, orthopedic trauma, joint reconstruction, enabling surgical technologies, and neuromodulation. The company targets orthopedic surgeons, neurosurgeons, and healthcare institutions. Its growth strategy emphasizes organic product innovation combined with selective acquisitions and operational efficiency improvements under new leadership following a CEO transition in 2025. Globus Medical remains committed to advancing patient outcomes through superior engineering and a comprehensive range of musculoskeletal solutions.
Company News
What Makes Globus Medical (GMED) a New Strong Buy Stock
Top Robotics Stocks to Add to Your Portfolio for Impressive Returns
GMED vs. ITGR: Which Stock Should Value Investors Buy Now?
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
New Strong Buy Stocks for September 11th
3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes
3 Sales Growth Stocks to Buy Amid Renewed Middle East Tensions
New Strong Buy Stocks for September 9th
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
3 Reasons Growth Investors Will Love Globus Medical (GMED)
Wall Street Analysts Believe Globus Medical (GMED) Could Rally 25.03%: Here's is How to Trade
GMED or ITGR: Which Is the Better Value Stock Right Now?
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy?
American Capital Management Inc. Takes Position in Globus Medical, Inc. $GMED
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
Here's Why Globus Medical (GMED) is a Strong Value Stock
4 High-Growth GARP Stocks With Discounted PEG Ratios for 2026
Globus Medical: 7 Quarters Of Margin Expansion, Priced For None
Here is Why Growth Investors Should Buy Globus Medical (GMED) Now
Globus Medical (GMED) Upgraded to Strong Buy: Here's Why